aap Implantate Overview
- Year Founded
-
1990
- Status
-
Public
- Employees
-
101
- Stock Symbol
-
AAQ1
- Investments
-
5
- Share Price
-
$1.65
- (As of Wednesday Closing)
aap Implantate General Information
Description
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
Contact Information
Website
www.aap.deCorporate Office
- Lorenzweg 5
- 12099 Berlin
- Germany
Corporate Office
- Lorenzweg 5
- 12099 Berlin
- Germany
aap Implantate Timeline
aap Implantate Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.65 | $1.38 | $0.75 - $1.67 | $18.1M | 11M | 3.82K | -$0.53 |
aap Implantate Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 13,709 | 9,155 | 12,047 | 19,908 |
Revenue | 13,048 | 12,420 | 12,108 | 14,384 |
EBITDA | (2,658) | (3,812) | (1,649) | (615) |
Net Income | (4,350) | (5,546) | (2,696) | (3,191) |
Total Assets | 20,695 | 21,524 | 21,692 | 25,989 |
Total Debt | 3,576 | 5,850 | 4,217 | 6,725 |
aap Implantate Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
aap Implantate Comparisons
Industry
Financing
Details
aap Implantate Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Orchid Orthopedic Solutions | Private Equity-Backed | Mason, MI | ||||
Stryker | Formerly VC-backed | Portage, MI | ||||
Lemaitre Vascular | Formerly PE-Backed | Burlington, MA | ||||
Spinal Elements | Private Equity-Backed | Carlsbad, CA | ||||
Vascular Graft Solutions | Private Equity-Backed | Tel Aviv, Israel |
aap Implantate Patents
aap Implantate Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3645761-A1 | Magnesium alloy, biodegradable implant and method for producing a biodegradable implant | Pending | 27-Jun-2017 | ||
US-20200123636-A1 | Magnesium alloy, biodegradable implant and method for producing a biodegradable implant | Inactive | 27-Jun-2017 | ||
DE-102015115878-B4 | A method of treating a metallic surface and bodies having a treated metallic surface | Active | 21-Sep-2015 | ||
DE-102015115878-A1 | A method of treating a metallic surface and bodies having a treated metallic surface | Active | 21-Sep-2015 | ||
US-20180256781-A1 | Method for treating a metal surface and body, comprising a treated metal surface | Inactive | 21-Sep-2015 | A61L27/306 |
aap Implantate Executive Team (5)
Name | Title | Board Seat |
---|---|---|
Rubino Di Girolamo | Chief Executive Officer & Chairman of the Management Board | |
Agnieszka Mierzejewska | Chief Operating Officer & Board Member |
aap Implantate Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
aap Implantate | Chief Operating Officer & Board Member | ||
aap Implantate | Vice Chairwoman of the Supervisory Board | ||
aap Implantate | Chief Executive Officer & Chairman of the Management Board |
aap Implantate Signals
aap Implantate Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
aap Implantate Investments & Acquisitions (5)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
European Medical Contract Manufacturing | 11-Dec-2006 | Medical Supplies | |||
Osartis | 25-Oct-2005 | Distributors (Healthcare) | |||
ADC Advanced Dental Care | 01-Oct-2005 | Medical Supplies | |||
Coripharm, Mebio and Corimed | 30-Nov-2000 | Therapeutic Devices | |||
Osartis | 30-Nov-2000 | Corporate | Distributors (Healthcare) |
aap Implantate ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
aap Implantate Exits (3)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
European Medical Contract Manufacturing | 11-Dec-2006 | Completed |
|
||
Osartis | 25-Oct-2005 | Completed |
|
||
Osartis | 30-Nov-2000 | Corporate | Completed |
aap Implantate FAQs
-
When was aap Implantate founded?
aap Implantate was founded in 1990.
-
Who is the CEO of aap Implantate?
Rubino Di Girolamo is the CEO of aap Implantate.
-
Where is aap Implantate headquartered?
aap Implantate is headquartered in Berlin, Germany.
-
What is the size of aap Implantate?
aap Implantate has 101 total employees.
-
What industry is aap Implantate in?
aap Implantate’s primary industry is Surgical Devices.
-
Is aap Implantate a private or public company?
aap Implantate is a Public company.
-
What is aap Implantate’s stock symbol?
The ticker symbol for aap Implantate is AAQ1.
-
What is the current stock price of aap Implantate?
As of 02-Oct-2024 the stock price of aap Implantate is $1.65.
-
What is the current market cap of aap Implantate?
The current market capitalization of aap Implantate is $18.1M.
-
What is aap Implantate’s current revenue?
The trailing twelve month revenue for aap Implantate is $13M.
-
Who are aap Implantate’s competitors?
Orchid Orthopedic Solutions, Stryker, Lemaitre Vascular, Spinal Elements, and Vascular Graft Solutions are some of the 16 competitors of aap Implantate.
-
What is aap Implantate’s annual earnings per share (EPS)?
aap Implantate’s EPS for 12 months was -$0.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »